世界のデジタル慢性疾患管理市場の成長(現状と展望)2023-2029年Global Digital Chronic Disease Management Market Growth (Status and Outlook) 2023-2029 LPI(LPインフォメーション)の最新調査によると、世界のデジタル慢性疾患管理市場規模は2022年に100万米ドルと評価されました。川下市場での需要拡大とCOVID-19やロシア・ウクライナ戦争の影響からの回復により... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーLPI(LPインフォメーション)の最新調査によると、世界のデジタル慢性疾患管理市場規模は2022年に100万米ドルと評価されました。川下市場での需要拡大とCOVID-19やロシア・ウクライナ戦争の影響からの回復により、デジタル慢性疾患管理は2029年までに100万米ドルの再調整規模になると予測され、レビュー期間中のCAGRは%である。この調査レポートは、世界のデジタル慢性疾患管理市場の成長可能性を明らかにしています。COVID-19やロシア・ウクライナ戦争の影響からの回復に伴い、デジタル慢性疾患管理は今後の市場で安定した成長を示すと予想される。しかし、製品の差別化、コスト削減、サプライチェーンの最適化は、デジタル慢性疾患管理を広く普及させるために引き続き重要である。市場参入企業は、デジタル慢性疾患管理市場が提供する膨大な機会を活用するために、研究開発への投資、戦略的パートナーシップの構築、進化する消費者の嗜好に合わせた製品提供を行う必要があります。 デジタル慢性疾患管理とは、慢性非伝染性疾患とその危険因子の定期的な検出、継続的なモニタリング、評価、包括的な介入管理を行うために、オンライン・ソフトウェアやインテリジェント・ハードウェアを使用する医療行為とプロセスを指す。疾病リスク予測、早期警告、包括的介入だけでなく、慢性疾患集団の包括的管理、慢性疾患の影響評価なども含まれる。 主な特徴 デジタル慢性疾患管理市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、デジタル慢性疾患管理市場の現在の規模と成長の概要を提供します。過去のデータ、タイプ別(有料、無料など)の市場細分化、地域別内訳などが含まれます。 市場促進要因と課題:政府規制、環境問題、技術進歩、消費者嗜好の変化など、デジタル慢性疾患管理市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制約、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。 競合情勢:この調査レポートは、デジタル慢性疾患管理市場における競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれています。また、新興プレーヤーとその潜在的な市場への影響も強調することができます。 技術開発:調査レポートは、デジタル慢性疾患管理業界における最新の技術開発を掘り下げることができます。これには、デジタル慢性疾患管理技術の進歩、デジタル慢性疾患管理の新規参入、デジタル慢性疾患管理の新規投資、デジタル慢性疾患管理の将来を形作るその他のイノベーションなどが含まれます。 川下の事業者の好み:本レポートは、デジタル慢性疾患管理市場における顧客の購買行動や採用動向を明らかにします。顧客の購買決定やデジタル慢性疾患管理製品の嗜好に影響を与える要因も含まれます。 政府の政策とインセンティブ調査レポートは、政府の政策やインセンティブがデジタル慢性疾患管理市場に与える影響を分析します。これには、デジタル慢性疾患管理市場の促進を目的とした規制枠組み、補助金、税制優遇措置などの評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。 環境への影響と持続可能性調査レポートは、デジタル慢性疾患管理市場の環境影響と持続可能性の側面を評価します。 市場予測と将来展望:実施した分析に基づき、調査レポートはデジタル慢性疾患管理産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会本レポートでは最後に、業界関係者、政策立案者、投資家への提言を行っています。市場関係者が新たなトレンドを活用し、課題を克服し、デジタル慢性疾患管理市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場細分化: デジタル慢性疾患管理市場は、タイプ別と用途別に分類されます。2018年から2029年までの期間について、セグメント間の成長により、タイプ別、およびアプリケーション別の消費額の正確な計算と予測を提供します。 タイプ別セグメント チャージ 無料 用途別セグメント 医療機関 薬局 慢性疾患患者 本レポートでは、市場を地域別にも分割しています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 S3 コネクテッド・ヘルス ウェルドック アストラゼネカ NTTデータ クレドヘルスサービス ドーンヘルス バイエル メドトロニック テラドックヘルス サイエンスソフト トライゼット・ヘルスケア(コグニザント) オマダヘルス ファブル パックヘルス エピック・システムズ パスメイト エブリドーズ Aptar デジタルヘルス VITech ClouDrグループ JDヘルス アリヘルス 平安グッドドクター Weドクターグループ ウェイ・マイ メドリンカー 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Digital Chronic Disease Management Market Size 2018-2029 2.1.2 Digital Chronic Disease Management Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Digital Chronic Disease Management Segment by Type 2.2.1 Charge 2.2.2 Free 2.3 Digital Chronic Disease Management Market Size by Type 2.3.1 Digital Chronic Disease Management Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Digital Chronic Disease Management Market Size Market Share by Type (2018-2023) 2.4 Digital Chronic Disease Management Segment by Application 2.4.1 Medical Institutions 2.4.2 Pharmacy 2.4.3 Chronic Disease Patients 2.5 Digital Chronic Disease Management Market Size by Application 2.5.1 Digital Chronic Disease Management Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Digital Chronic Disease Management Market Size Market Share by Application (2018-2023) 3 Digital Chronic Disease Management Market Size by Player 3.1 Digital Chronic Disease Management Market Size Market Share by Players 3.1.1 Global Digital Chronic Disease Management Revenue by Players (2018-2023) 3.1.2 Global Digital Chronic Disease Management Revenue Market Share by Players (2018-2023) 3.2 Global Digital Chronic Disease Management Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Digital Chronic Disease Management by Regions 4.1 Digital Chronic Disease Management Market Size by Regions (2018-2023) 4.2 Americas Digital Chronic Disease Management Market Size Growth (2018-2023) 4.3 APAC Digital Chronic Disease Management Market Size Growth (2018-2023) 4.4 Europe Digital Chronic Disease Management Market Size Growth (2018-2023) 4.5 Middle East & Africa Digital Chronic Disease Management Market Size Growth (2018-2023) 5 Americas 5.1 Americas Digital Chronic Disease Management Market Size by Country (2018-2023) 5.2 Americas Digital Chronic Disease Management Market Size by Type (2018-2023) 5.3 Americas Digital Chronic Disease Management Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Digital Chronic Disease Management Market Size by Region (2018-2023) 6.2 APAC Digital Chronic Disease Management Market Size by Type (2018-2023) 6.3 APAC Digital Chronic Disease Management Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Digital Chronic Disease Management by Country (2018-2023) 7.2 Europe Digital Chronic Disease Management Market Size by Type (2018-2023) 7.3 Europe Digital Chronic Disease Management Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Digital Chronic Disease Management by Region (2018-2023) 8.2 Middle East & Africa Digital Chronic Disease Management Market Size by Type (2018-2023) 8.3 Middle East & Africa Digital Chronic Disease Management Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Digital Chronic Disease Management Market Forecast 10.1 Global Digital Chronic Disease Management Forecast by Regions (2024-2029) 10.1.1 Global Digital Chronic Disease Management Forecast by Regions (2024-2029) 10.1.2 Americas Digital Chronic Disease Management Forecast 10.1.3 APAC Digital Chronic Disease Management Forecast 10.1.4 Europe Digital Chronic Disease Management Forecast 10.1.5 Middle East & Africa Digital Chronic Disease Management Forecast 10.2 Americas Digital Chronic Disease Management Forecast by Country (2024-2029) 10.2.1 United States Digital Chronic Disease Management Market Forecast 10.2.2 Canada Digital Chronic Disease Management Market Forecast 10.2.3 Mexico Digital Chronic Disease Management Market Forecast 10.2.4 Brazil Digital Chronic Disease Management Market Forecast 10.3 APAC Digital Chronic Disease Management Forecast by Region (2024-2029) 10.3.1 China Digital Chronic Disease Management Market Forecast 10.3.2 Japan Digital Chronic Disease Management Market Forecast 10.3.3 Korea Digital Chronic Disease Management Market Forecast 10.3.4 Southeast Asia Digital Chronic Disease Management Market Forecast 10.3.5 India Digital Chronic Disease Management Market Forecast 10.3.6 Australia Digital Chronic Disease Management Market Forecast 10.4 Europe Digital Chronic Disease Management Forecast by Country (2024-2029) 10.4.1 Germany Digital Chronic Disease Management Market Forecast 10.4.2 France Digital Chronic Disease Management Market Forecast 10.4.3 UK Digital Chronic Disease Management Market Forecast 10.4.4 Italy Digital Chronic Disease Management Market Forecast 10.4.5 Russia Digital Chronic Disease Management Market Forecast 10.5 Middle East & Africa Digital Chronic Disease Management Forecast by Region (2024-2029) 10.5.1 Egypt Digital Chronic Disease Management Market Forecast 10.5.2 South Africa Digital Chronic Disease Management Market Forecast 10.5.3 Israel Digital Chronic Disease Management Market Forecast 10.5.4 Turkey Digital Chronic Disease Management Market Forecast 10.5.5 GCC Countries Digital Chronic Disease Management Market Forecast 10.6 Global Digital Chronic Disease Management Forecast by Type (2024-2029) 10.7 Global Digital Chronic Disease Management Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 S3 Connected Health 11.1.1 S3 Connected Health Company Information 11.1.2 S3 Connected Health Digital Chronic Disease Management Product Offered 11.1.3 S3 Connected Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 S3 Connected Health Main Business Overview 11.1.5 S3 Connected Health Latest Developments 11.2 WellDoc 11.2.1 WellDoc Company Information 11.2.2 WellDoc Digital Chronic Disease Management Product Offered 11.2.3 WellDoc Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 WellDoc Main Business Overview 11.2.5 WellDoc Latest Developments 11.3 AstraZeneca 11.3.1 AstraZeneca Company Information 11.3.2 AstraZeneca Digital Chronic Disease Management Product Offered 11.3.3 AstraZeneca Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 AstraZeneca Main Business Overview 11.3.5 AstraZeneca Latest Developments 11.4 NTT DATA 11.4.1 NTT DATA Company Information 11.4.2 NTT DATA Digital Chronic Disease Management Product Offered 11.4.3 NTT DATA Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 NTT DATA Main Business Overview 11.4.5 NTT DATA Latest Developments 11.5 Credo Health Services 11.5.1 Credo Health Services Company Information 11.5.2 Credo Health Services Digital Chronic Disease Management Product Offered 11.5.3 Credo Health Services Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Credo Health Services Main Business Overview 11.5.5 Credo Health Services Latest Developments 11.6 Dawn Health 11.6.1 Dawn Health Company Information 11.6.2 Dawn Health Digital Chronic Disease Management Product Offered 11.6.3 Dawn Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Dawn Health Main Business Overview 11.6.5 Dawn Health Latest Developments 11.7 Bayer 11.7.1 Bayer Company Information 11.7.2 Bayer Digital Chronic Disease Management Product Offered 11.7.3 Bayer Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Bayer Main Business Overview 11.7.5 Bayer Latest Developments 11.8 Medtronic 11.8.1 Medtronic Company Information 11.8.2 Medtronic Digital Chronic Disease Management Product Offered 11.8.3 Medtronic Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 Medtronic Main Business Overview 11.8.5 Medtronic Latest Developments 11.9 Teladoc Health 11.9.1 Teladoc Health Company Information 11.9.2 Teladoc Health Digital Chronic Disease Management Product Offered 11.9.3 Teladoc Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 Teladoc Health Main Business Overview 11.9.5 Teladoc Health Latest Developments 11.10 ScienceSoft 11.10.1 ScienceSoft Company Information 11.10.2 ScienceSoft Digital Chronic Disease Management Product Offered 11.10.3 ScienceSoft Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 ScienceSoft Main Business Overview 11.10.5 ScienceSoft Latest Developments 11.11 TriZetto Healthcare (Cognizant) 11.11.1 TriZetto Healthcare (Cognizant) Company Information 11.11.2 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Offered 11.11.3 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.11.4 TriZetto Healthcare (Cognizant) Main Business Overview 11.11.5 TriZetto Healthcare (Cognizant) Latest Developments 11.12 Omada Health 11.12.1 Omada Health Company Information 11.12.2 Omada Health Digital Chronic Disease Management Product Offered 11.12.3 Omada Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.12.4 Omada Health Main Business Overview 11.12.5 Omada Health Latest Developments 11.13 Phable 11.13.1 Phable Company Information 11.13.2 Phable Digital Chronic Disease Management Product Offered 11.13.3 Phable Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.13.4 Phable Main Business Overview 11.13.5 Phable Latest Developments 11.14 Pack Health 11.14.1 Pack Health Company Information 11.14.2 Pack Health Digital Chronic Disease Management Product Offered 11.14.3 Pack Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.14.4 Pack Health Main Business Overview 11.14.5 Pack Health Latest Developments 11.15 Epic Systems 11.15.1 Epic Systems Company Information 11.15.2 Epic Systems Digital Chronic Disease Management Product Offered 11.15.3 Epic Systems Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.15.4 Epic Systems Main Business Overview 11.15.5 Epic Systems Latest Developments 11.16 Pathmate 11.16.1 Pathmate Company Information 11.16.2 Pathmate Digital Chronic Disease Management Product Offered 11.16.3 Pathmate Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.16.4 Pathmate Main Business Overview 11.16.5 Pathmate Latest Developments 11.17 EveryDose 11.17.1 EveryDose Company Information 11.17.2 EveryDose Digital Chronic Disease Management Product Offered 11.17.3 EveryDose Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.17.4 EveryDose Main Business Overview 11.17.5 EveryDose Latest Developments 11.18 Aptar Digital Health 11.18.1 Aptar Digital Health Company Information 11.18.2 Aptar Digital Health Digital Chronic Disease Management Product Offered 11.18.3 Aptar Digital Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.18.4 Aptar Digital Health Main Business Overview 11.18.5 Aptar Digital Health Latest Developments 11.19 VITech 11.19.1 VITech Company Information 11.19.2 VITech Digital Chronic Disease Management Product Offered 11.19.3 VITech Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.19.4 VITech Main Business Overview 11.19.5 VITech Latest Developments 11.20 ClouDr Group 11.20.1 ClouDr Group Company Information 11.20.2 ClouDr Group Digital Chronic Disease Management Product Offered 11.20.3 ClouDr Group Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.20.4 ClouDr Group Main Business Overview 11.20.5 ClouDr Group Latest Developments 11.21 JD Health 11.21.1 JD Health Company Information 11.21.2 JD Health Digital Chronic Disease Management Product Offered 11.21.3 JD Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.21.4 JD Health Main Business Overview 11.21.5 JD Health Latest Developments 11.22 Ali Health 11.22.1 Ali Health Company Information 11.22.2 Ali Health Digital Chronic Disease Management Product Offered 11.22.3 Ali Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.22.4 Ali Health Main Business Overview 11.22.5 Ali Health Latest Developments 11.23 Ping An Good Doctor 11.23.1 Ping An Good Doctor Company Information 11.23.2 Ping An Good Doctor Digital Chronic Disease Management Product Offered 11.23.3 Ping An Good Doctor Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.23.4 Ping An Good Doctor Main Business Overview 11.23.5 Ping An Good Doctor Latest Developments 11.24 We Doctor Group 11.24.1 We Doctor Group Company Information 11.24.2 We Doctor Group Digital Chronic Disease Management Product Offered 11.24.3 We Doctor Group Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.24.4 We Doctor Group Main Business Overview 11.24.5 We Doctor Group Latest Developments 11.25 Wei Mai 11.25.1 Wei Mai Company Information 11.25.2 Wei Mai Digital Chronic Disease Management Product Offered 11.25.3 Wei Mai Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.25.4 Wei Mai Main Business Overview 11.25.5 Wei Mai Latest Developments 11.26 Medlinker 11.26.1 Medlinker Company Information 11.26.2 Medlinker Digital Chronic Disease Management Product Offered 11.26.3 Medlinker Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.26.4 Medlinker Main Business Overview 11.26.5 Medlinker Latest Developments 12 Research Findings and Conclusion
SummaryAccording to our LPI (LP Information) latest study, the global Digital Chronic Disease Management market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Digital Chronic Disease Management is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Digital Chronic Disease Management Market Size 2018-2029 2.1.2 Digital Chronic Disease Management Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Digital Chronic Disease Management Segment by Type 2.2.1 Charge 2.2.2 Free 2.3 Digital Chronic Disease Management Market Size by Type 2.3.1 Digital Chronic Disease Management Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Digital Chronic Disease Management Market Size Market Share by Type (2018-2023) 2.4 Digital Chronic Disease Management Segment by Application 2.4.1 Medical Institutions 2.4.2 Pharmacy 2.4.3 Chronic Disease Patients 2.5 Digital Chronic Disease Management Market Size by Application 2.5.1 Digital Chronic Disease Management Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Digital Chronic Disease Management Market Size Market Share by Application (2018-2023) 3 Digital Chronic Disease Management Market Size by Player 3.1 Digital Chronic Disease Management Market Size Market Share by Players 3.1.1 Global Digital Chronic Disease Management Revenue by Players (2018-2023) 3.1.2 Global Digital Chronic Disease Management Revenue Market Share by Players (2018-2023) 3.2 Global Digital Chronic Disease Management Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Digital Chronic Disease Management by Regions 4.1 Digital Chronic Disease Management Market Size by Regions (2018-2023) 4.2 Americas Digital Chronic Disease Management Market Size Growth (2018-2023) 4.3 APAC Digital Chronic Disease Management Market Size Growth (2018-2023) 4.4 Europe Digital Chronic Disease Management Market Size Growth (2018-2023) 4.5 Middle East & Africa Digital Chronic Disease Management Market Size Growth (2018-2023) 5 Americas 5.1 Americas Digital Chronic Disease Management Market Size by Country (2018-2023) 5.2 Americas Digital Chronic Disease Management Market Size by Type (2018-2023) 5.3 Americas Digital Chronic Disease Management Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Digital Chronic Disease Management Market Size by Region (2018-2023) 6.2 APAC Digital Chronic Disease Management Market Size by Type (2018-2023) 6.3 APAC Digital Chronic Disease Management Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Digital Chronic Disease Management by Country (2018-2023) 7.2 Europe Digital Chronic Disease Management Market Size by Type (2018-2023) 7.3 Europe Digital Chronic Disease Management Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Digital Chronic Disease Management by Region (2018-2023) 8.2 Middle East & Africa Digital Chronic Disease Management Market Size by Type (2018-2023) 8.3 Middle East & Africa Digital Chronic Disease Management Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Digital Chronic Disease Management Market Forecast 10.1 Global Digital Chronic Disease Management Forecast by Regions (2024-2029) 10.1.1 Global Digital Chronic Disease Management Forecast by Regions (2024-2029) 10.1.2 Americas Digital Chronic Disease Management Forecast 10.1.3 APAC Digital Chronic Disease Management Forecast 10.1.4 Europe Digital Chronic Disease Management Forecast 10.1.5 Middle East & Africa Digital Chronic Disease Management Forecast 10.2 Americas Digital Chronic Disease Management Forecast by Country (2024-2029) 10.2.1 United States Digital Chronic Disease Management Market Forecast 10.2.2 Canada Digital Chronic Disease Management Market Forecast 10.2.3 Mexico Digital Chronic Disease Management Market Forecast 10.2.4 Brazil Digital Chronic Disease Management Market Forecast 10.3 APAC Digital Chronic Disease Management Forecast by Region (2024-2029) 10.3.1 China Digital Chronic Disease Management Market Forecast 10.3.2 Japan Digital Chronic Disease Management Market Forecast 10.3.3 Korea Digital Chronic Disease Management Market Forecast 10.3.4 Southeast Asia Digital Chronic Disease Management Market Forecast 10.3.5 India Digital Chronic Disease Management Market Forecast 10.3.6 Australia Digital Chronic Disease Management Market Forecast 10.4 Europe Digital Chronic Disease Management Forecast by Country (2024-2029) 10.4.1 Germany Digital Chronic Disease Management Market Forecast 10.4.2 France Digital Chronic Disease Management Market Forecast 10.4.3 UK Digital Chronic Disease Management Market Forecast 10.4.4 Italy Digital Chronic Disease Management Market Forecast 10.4.5 Russia Digital Chronic Disease Management Market Forecast 10.5 Middle East & Africa Digital Chronic Disease Management Forecast by Region (2024-2029) 10.5.1 Egypt Digital Chronic Disease Management Market Forecast 10.5.2 South Africa Digital Chronic Disease Management Market Forecast 10.5.3 Israel Digital Chronic Disease Management Market Forecast 10.5.4 Turkey Digital Chronic Disease Management Market Forecast 10.5.5 GCC Countries Digital Chronic Disease Management Market Forecast 10.6 Global Digital Chronic Disease Management Forecast by Type (2024-2029) 10.7 Global Digital Chronic Disease Management Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 S3 Connected Health 11.1.1 S3 Connected Health Company Information 11.1.2 S3 Connected Health Digital Chronic Disease Management Product Offered 11.1.3 S3 Connected Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 S3 Connected Health Main Business Overview 11.1.5 S3 Connected Health Latest Developments 11.2 WellDoc 11.2.1 WellDoc Company Information 11.2.2 WellDoc Digital Chronic Disease Management Product Offered 11.2.3 WellDoc Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 WellDoc Main Business Overview 11.2.5 WellDoc Latest Developments 11.3 AstraZeneca 11.3.1 AstraZeneca Company Information 11.3.2 AstraZeneca Digital Chronic Disease Management Product Offered 11.3.3 AstraZeneca Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 AstraZeneca Main Business Overview 11.3.5 AstraZeneca Latest Developments 11.4 NTT DATA 11.4.1 NTT DATA Company Information 11.4.2 NTT DATA Digital Chronic Disease Management Product Offered 11.4.3 NTT DATA Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 NTT DATA Main Business Overview 11.4.5 NTT DATA Latest Developments 11.5 Credo Health Services 11.5.1 Credo Health Services Company Information 11.5.2 Credo Health Services Digital Chronic Disease Management Product Offered 11.5.3 Credo Health Services Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Credo Health Services Main Business Overview 11.5.5 Credo Health Services Latest Developments 11.6 Dawn Health 11.6.1 Dawn Health Company Information 11.6.2 Dawn Health Digital Chronic Disease Management Product Offered 11.6.3 Dawn Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Dawn Health Main Business Overview 11.6.5 Dawn Health Latest Developments 11.7 Bayer 11.7.1 Bayer Company Information 11.7.2 Bayer Digital Chronic Disease Management Product Offered 11.7.3 Bayer Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Bayer Main Business Overview 11.7.5 Bayer Latest Developments 11.8 Medtronic 11.8.1 Medtronic Company Information 11.8.2 Medtronic Digital Chronic Disease Management Product Offered 11.8.3 Medtronic Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 Medtronic Main Business Overview 11.8.5 Medtronic Latest Developments 11.9 Teladoc Health 11.9.1 Teladoc Health Company Information 11.9.2 Teladoc Health Digital Chronic Disease Management Product Offered 11.9.3 Teladoc Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 Teladoc Health Main Business Overview 11.9.5 Teladoc Health Latest Developments 11.10 ScienceSoft 11.10.1 ScienceSoft Company Information 11.10.2 ScienceSoft Digital Chronic Disease Management Product Offered 11.10.3 ScienceSoft Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 ScienceSoft Main Business Overview 11.10.5 ScienceSoft Latest Developments 11.11 TriZetto Healthcare (Cognizant) 11.11.1 TriZetto Healthcare (Cognizant) Company Information 11.11.2 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Offered 11.11.3 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.11.4 TriZetto Healthcare (Cognizant) Main Business Overview 11.11.5 TriZetto Healthcare (Cognizant) Latest Developments 11.12 Omada Health 11.12.1 Omada Health Company Information 11.12.2 Omada Health Digital Chronic Disease Management Product Offered 11.12.3 Omada Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.12.4 Omada Health Main Business Overview 11.12.5 Omada Health Latest Developments 11.13 Phable 11.13.1 Phable Company Information 11.13.2 Phable Digital Chronic Disease Management Product Offered 11.13.3 Phable Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.13.4 Phable Main Business Overview 11.13.5 Phable Latest Developments 11.14 Pack Health 11.14.1 Pack Health Company Information 11.14.2 Pack Health Digital Chronic Disease Management Product Offered 11.14.3 Pack Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.14.4 Pack Health Main Business Overview 11.14.5 Pack Health Latest Developments 11.15 Epic Systems 11.15.1 Epic Systems Company Information 11.15.2 Epic Systems Digital Chronic Disease Management Product Offered 11.15.3 Epic Systems Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.15.4 Epic Systems Main Business Overview 11.15.5 Epic Systems Latest Developments 11.16 Pathmate 11.16.1 Pathmate Company Information 11.16.2 Pathmate Digital Chronic Disease Management Product Offered 11.16.3 Pathmate Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.16.4 Pathmate Main Business Overview 11.16.5 Pathmate Latest Developments 11.17 EveryDose 11.17.1 EveryDose Company Information 11.17.2 EveryDose Digital Chronic Disease Management Product Offered 11.17.3 EveryDose Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.17.4 EveryDose Main Business Overview 11.17.5 EveryDose Latest Developments 11.18 Aptar Digital Health 11.18.1 Aptar Digital Health Company Information 11.18.2 Aptar Digital Health Digital Chronic Disease Management Product Offered 11.18.3 Aptar Digital Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.18.4 Aptar Digital Health Main Business Overview 11.18.5 Aptar Digital Health Latest Developments 11.19 VITech 11.19.1 VITech Company Information 11.19.2 VITech Digital Chronic Disease Management Product Offered 11.19.3 VITech Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.19.4 VITech Main Business Overview 11.19.5 VITech Latest Developments 11.20 ClouDr Group 11.20.1 ClouDr Group Company Information 11.20.2 ClouDr Group Digital Chronic Disease Management Product Offered 11.20.3 ClouDr Group Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.20.4 ClouDr Group Main Business Overview 11.20.5 ClouDr Group Latest Developments 11.21 JD Health 11.21.1 JD Health Company Information 11.21.2 JD Health Digital Chronic Disease Management Product Offered 11.21.3 JD Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.21.4 JD Health Main Business Overview 11.21.5 JD Health Latest Developments 11.22 Ali Health 11.22.1 Ali Health Company Information 11.22.2 Ali Health Digital Chronic Disease Management Product Offered 11.22.3 Ali Health Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.22.4 Ali Health Main Business Overview 11.22.5 Ali Health Latest Developments 11.23 Ping An Good Doctor 11.23.1 Ping An Good Doctor Company Information 11.23.2 Ping An Good Doctor Digital Chronic Disease Management Product Offered 11.23.3 Ping An Good Doctor Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.23.4 Ping An Good Doctor Main Business Overview 11.23.5 Ping An Good Doctor Latest Developments 11.24 We Doctor Group 11.24.1 We Doctor Group Company Information 11.24.2 We Doctor Group Digital Chronic Disease Management Product Offered 11.24.3 We Doctor Group Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.24.4 We Doctor Group Main Business Overview 11.24.5 We Doctor Group Latest Developments 11.25 Wei Mai 11.25.1 Wei Mai Company Information 11.25.2 Wei Mai Digital Chronic Disease Management Product Offered 11.25.3 Wei Mai Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.25.4 Wei Mai Main Business Overview 11.25.5 Wei Mai Latest Developments 11.26 Medlinker 11.26.1 Medlinker Company Information 11.26.2 Medlinker Digital Chronic Disease Management Product Offered 11.26.3 Medlinker Digital Chronic Disease Management Revenue, Gross Margin and Market Share (2018-2023) 11.26.4 Medlinker Main Business Overview 11.26.5 Medlinker Latest Developments 12 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(ソフトウェア)の最新刊レポート
LP Information社のサービス・ソフトウェア分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |